Approvals/CIMA-AEMPS/BENDAMUSTINA AUROVITAS 2.5 MG/ML POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG

Approved

STANDARD

BENDAMUSTINA AUROVITAS 2.5 MG/ML POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG

Eugia Pharma (Malta) Limited🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 4362bdb95b9a19e9
Drug Cima Aemps Name: BENDAMUSTINA AUROVITAS 2.5 MG/ML POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG
Register Number: 87928
Holder Company Name: Eugia Pharma (Malta) Limited
Marketing Company Name: Aurovitas Spain, S.A.U.
Authorization Date: 2022-07-29
Dosage Form: POLVO PARA CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose: 2.5 mg/ml
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: Yes
Company Name: Eugia Pharma (Malta) Limited

BENDAMUSTINA HIDROCLORURO MONOHIDRATO

26,14 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jul 29, 2022

Approval ID

4362bdb95b9a19e9

Type

Standard